Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases

Marcia A. Blackman, Mark A. Marchionni, John Gilly, Matthew Hepburn, Bruce L. Innis, Alan Barrett, Kent E. Kester, John R. Mascola, James F. Cummings, Thomas P. Monath, M. Cristina Cassetti, Jerome H. Kim, Melanie Saville, Stephen J. Thomas

Research output: Contribution to journalArticle

Abstract

Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current “gaps,” and prospect what could be done to improve our position. Herein we describe the summit proceedings, “Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases,” held October 2–3, 2018, at the Trudeau Institute in Saranac Lake, NY.

Original languageEnglish (US)
Pages (from-to)6248-6254
Number of pages7
JournalVaccine
Volume37
Issue number43
DOIs
StatePublished - Oct 8 2019

Fingerprint

emerging diseases
biomedical research
Virus Diseases
research and development
deforestation
immunology
urbanization
travel
public health
vaccination
climate change
Emerging Communicable Diseases
vaccines
lakes
therapeutics
Urbanization
Biological Science Disciplines
Climate Change
Conservation of Natural Resources
Lakes

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Blackman, M. A., Marchionni, M. A., Gilly, J., Hepburn, M., Innis, B. L., Barrett, A., ... Thomas, S. J. (2019). Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases. Vaccine, 37(43), 6248-6254. https://doi.org/10.1016/j.vaccine.2019.08.061

Summit proceedings : Biomedical countermeasure development for emerging vector-borne viral diseases. / Blackman, Marcia A.; Marchionni, Mark A.; Gilly, John; Hepburn, Matthew; Innis, Bruce L.; Barrett, Alan; Kester, Kent E.; Mascola, John R.; Cummings, James F.; Monath, Thomas P.; Cassetti, M. Cristina; Kim, Jerome H.; Saville, Melanie; Thomas, Stephen J.

In: Vaccine, Vol. 37, No. 43, 08.10.2019, p. 6248-6254.

Research output: Contribution to journalArticle

Blackman, MA, Marchionni, MA, Gilly, J, Hepburn, M, Innis, BL, Barrett, A, Kester, KE, Mascola, JR, Cummings, JF, Monath, TP, Cassetti, MC, Kim, JH, Saville, M & Thomas, SJ 2019, 'Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases', Vaccine, vol. 37, no. 43, pp. 6248-6254. https://doi.org/10.1016/j.vaccine.2019.08.061
Blackman, Marcia A. ; Marchionni, Mark A. ; Gilly, John ; Hepburn, Matthew ; Innis, Bruce L. ; Barrett, Alan ; Kester, Kent E. ; Mascola, John R. ; Cummings, James F. ; Monath, Thomas P. ; Cassetti, M. Cristina ; Kim, Jerome H. ; Saville, Melanie ; Thomas, Stephen J. / Summit proceedings : Biomedical countermeasure development for emerging vector-borne viral diseases. In: Vaccine. 2019 ; Vol. 37, No. 43. pp. 6248-6254.
@article{ac7f1c3759c1468b90006bd4f1f8f7f1,
title = "Summit proceedings: Biomedical countermeasure development for emerging vector-borne viral diseases",
abstract = "Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current “gaps,” and prospect what could be done to improve our position. Herein we describe the summit proceedings, “Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases,” held October 2–3, 2018, at the Trudeau Institute in Saranac Lake, NY.",
author = "Blackman, {Marcia A.} and Marchionni, {Mark A.} and John Gilly and Matthew Hepburn and Innis, {Bruce L.} and Alan Barrett and Kester, {Kent E.} and Mascola, {John R.} and Cummings, {James F.} and Monath, {Thomas P.} and Cassetti, {M. Cristina} and Kim, {Jerome H.} and Melanie Saville and Thomas, {Stephen J.}",
year = "2019",
month = "10",
day = "8",
doi = "10.1016/j.vaccine.2019.08.061",
language = "English (US)",
volume = "37",
pages = "6248--6254",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "43",

}

TY - JOUR

T1 - Summit proceedings

T2 - Biomedical countermeasure development for emerging vector-borne viral diseases

AU - Blackman, Marcia A.

AU - Marchionni, Mark A.

AU - Gilly, John

AU - Hepburn, Matthew

AU - Innis, Bruce L.

AU - Barrett, Alan

AU - Kester, Kent E.

AU - Mascola, John R.

AU - Cummings, James F.

AU - Monath, Thomas P.

AU - Cassetti, M. Cristina

AU - Kim, Jerome H.

AU - Saville, Melanie

AU - Thomas, Stephen J.

PY - 2019/10/8

Y1 - 2019/10/8

N2 - Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current “gaps,” and prospect what could be done to improve our position. Herein we describe the summit proceedings, “Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases,” held October 2–3, 2018, at the Trudeau Institute in Saranac Lake, NY.

AB - Emerging and re-emerging infectious diseases are an expanding global threat to public health, security, and economies. Increasing populations, urbanization, deforestation, climate change, anti-vaccination movements, war, and international travel are some of the contributing factors to this trend. The recent Ebola, MERS-CoV, and Zika outbreaks demonstrated we are insufficiently prepared to respond with proven safe and effective countermeasures (i.e., vaccines and therapeutics). The State University of New York Upstate Medical University and the Trudeau Institute convened a summit of key opinion and thought leaders in the life sciences and biomedical research and development enterprises to explore global biopreparedness challenges, take an inventory of existing capabilities and capacities related to preparation and response, assess current “gaps,” and prospect what could be done to improve our position. Herein we describe the summit proceedings, “Translational Immunology Supporting Biomedical Countermeasure Development for Emerging Vector-borne Viral Diseases,” held October 2–3, 2018, at the Trudeau Institute in Saranac Lake, NY.

UR - http://www.scopus.com/inward/record.url?scp=85071845032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85071845032&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2019.08.061

DO - 10.1016/j.vaccine.2019.08.061

M3 - Article

C2 - 31500964

AN - SCOPUS:85071845032

VL - 37

SP - 6248

EP - 6254

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 43

ER -